WELL Health Technologies Corp. - COO, Amir Javidan.
COO, Amir Javidan.
Source: WELL Health Technologies Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • WELL Health Technologies Corp. (WELL) has announced revenue milestones, new cybersecurity business offerings, and management changes
  • Revenue at its cybersecurity businesses have increased by 240 per cent year-over-year
  • Iain Paterson is now WELL’s CISO and Peter Giannoulis is CEO of subsidiary Cycura
  • WELL is expanding its incident response offering to implement cybersecurity solutions
  • Hamed Shabazi has transferred six million WELL shares into a family trust
  • WELL Health Technologies Corp. (WELL) is down 0.31 per cent trading at $3.24 per share as of 12:56 p.m. ET

Digital health company, WELL Health Technologies Corp. (WELL), has announced revenue milestones, new cybersecurity business offerings, and management changes.

WELL stated its cybersecurity businesses, Cycura and Source 44, achieved record revenue during the second quarter with an increase of 240 per cent year-over-year. The company believes this growth was primarily driven by an increasing customer base and expanding service offerings to its customers.

“We at WELL believe cybersecurity and patient data protection is one of our top priorities… and we look forward to providing more Canadian healthcare practitioners with the country’s most comprehensive security solution for outpatient medical clinics,” Amir Javidan, COO of WELL, said.

Alongside this accomplishment, WELL has appointed Iain Paterson as the company’s Chief Information Security Officer. Peter Giannoulis, the founder and CEO of Source 44, has been appointed as the new CEO of Cycura.

In other news, WELL explained that it has seen an increasing number of its customers who are experiencing cyber-attacks. To rectify this, WELL is expanding its incident response offering to implement cybersecurity solutions through SecureSolutionsNow.

Hamed Shahbazi, WELL’s founder, Chairman & CEO has transferred six million WELL shares (approximately 27.8 per cent) to a family trust. Shahbazi also exercised 1.7 million stock options that were set to expire in the next year.

WELL Health Technologies Corp. (WELL) is down 0.31 per cent trading at $3.24 per share as of 12:56 p.m. ET.

More From The Market Herald
Emerald Health Therapeutics Inc. - Director & Chairman, Jim Heppell.

" Emerald Health (CSE:EMH) shareholders approve merger

Emerald Health Therapeutics (EMH), has received shareholders’ approval for the proposed plan of arrangement with Skye Bioscience Inc.
Mydecine Innovations Group - CEO, Josh Bartch.

" Mydecine (NEO:MYCO) raises $244K and shifts management team

Mydecine Innovations Group (MYCO) has signed a common share subscription agreement with a third-party investor for proceeds up to $244,99.50.
PharmaDrug - CEO, Daniel Cohen

" PharmaDrug (CSE:PHRX) completes milestone to support cGMP production of PD-001

PharmaDrug (PHRX) has laid the groundwork to support cGMP production of cepharanthine-2HCL for use in the drug product production of PD-001.

" EQ (TSXV:EQ) reports strongest quarter in over a decade

EQ (EQ) reported its financial results for the second quarter ended June 30, 2022, announcing the highest second-quarter revenue in over a decade.